Corbenic Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5
| Closed | -$1K | – | 212 |
|
|
2022
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 217 |
|
|
2021
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 260 |
|
|
2021
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 261 |
|
|
2021
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 237 |
|
|
2021
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 227 |
|
|
2020
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 181 |
|
|
2020
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 153 |
|
|
2020
Q2 | $1K | Sell |
5
-6
| -55% | -$1.2K | ﹤0.01% | 145 |
|
|
2020
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 162 |
|
|
2019
Q4 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 167 |
|